Real-world outcomes of patients (pts) with malignant solid tumors treated with immune checkpoint inhibitors (ICI) in relation to smoking status

被引：0
|
作者：
El Saadany, T. [1 ]
Petrausch, U. [2 ]
Mora, A. R. [3 ]
Renner, C. [2 ]
Winder, T. [4 ]
Benda, M. [4 ]
Reimann, P. [4 ]
Jakob, A. [5 ]
Daza, A. C. [3 ]
Mueller, G. [3 ]
von Moos, R. [1 ,6 ,7 ]
Mark, M. [1 ,8 ]
机构：
[1] Cantonal Hosp Graubunden, Oncol Hematol, Chur, Switzerland
[2] Hirslanden Hosp, Oncol Hematol, Zurich, Switzerland
[3] Swiss Grp Clin Canc Res SAKK, Competence Ctr, Bern, Switzerland
[4] Hosp Feldkirch, Oncol Hematol, Feldkirch, Switzerland
[5] Hirslanden Hosp Aarau, Oncol Hematol, Aarau, Switzerland
[6] Cantonal Hosp Graubunden, Canc Ctr, Chur, Switzerland
[7] Cantonal Hosp Graubunden, Res Ctr, Chur, Switzerland
[8] Univ Svizzera Italiana, Oncol Hematol, Lugano, Switzerland
来源：
SWISS MEDICAL WEEKLY | 2023年 / 153卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
271
引用
收藏
页码：24S / 24S
页数：1
相关论文
共 50 条
  • [1] Real-world outcomes of patients (pts) with malignant solid tumors treated with immune checkpoint inhibitors (ICI) in relation to smoking status: The SAKK 80/19 SMOKER study
    El Saadany, Tamer
    Petrausch, Ulf
    Mora, Alfonso Rojas
    Winder, Thomas
    Renner, Christoph
    Benda, Magdalena
    Reimann, Patrick
    Froesch, Patrizia
    Jakob, Andreas
    Daza, Adriana Clavijo
    Mueller, Gisela
    Von Moos, Roger Anton Fredy
    Mark, Michael Thomas
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [2] Real-World Outcomes for Patients Treated With Immune Checkpoint Inhibitors in the Veterans Affairs System
    La, Jennifer
    Cheng, David
    Brophy, Mary T.
    Do, Nhan V.
    Lee, Jerry S. H.
    Tuck, David
    Fillmore, Nathanael R.
    JCO CLINICAL CANCER INFORMATICS, 2020, 4 : 918 - 928
  • [3] Outcomes in advanced hepatocellular carcinoma (HCC) patients (pts) treated with immune checkpoint inhibitors (ICI)
    Cowzer, D.
    Capanu, M.
    Keane, F.
    Khalil, D.
    Shia, J.
    Do, R.
    Chou, J.
    Walch, H.
    El Dika, I.
    Yaqubie, A.
    Solit, D.
    Berger, M.
    O'Reilly, E.
    Harding, J.
    Abou-Alfa, G.
    ANNALS OF ONCOLOGY, 2023, 34 : S109 - S109
  • [4] Real-world prognostic model for overall survival (OS) in patients (pts) with advanced urothelial cancer (aUC) treated with immune checkpoint inhibitors (ICI)
    Khaki, Ali Raza
    Diamantopoulos, Leonidas Nikolaos
    Miller, Natalie J.
    Bilen, Mehmet Asim
    Santos, Victor Sacristan
    Morales-Barrera, Rafael
    Devitt, Michael Edward
    Nelson, Ariel Ann
    Shreck, Evan
    Assi, Hussein
    Zakopoulou, Roubini
    Rodriguez-Vida, Alejo
    Lythgoe, Mark
    Drakaki, Alexandra
    Joshi, Monika
    Velho, Pedro Isaacsson
    Alonso, Lucia
    Galsky, Matt D.
    Sonpavde, Guru
    Grivas, Petros
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [5] Immune checkpoint inhibitors in patients with solid tumors and poor performance status A prospective data from the real-world settings
    Kapoor, Akhil
    Noronha, Vanita
    Patil, Vijay M.
    Menon, Nandini
    Joshi, Amit
    Abraham, George
    Prabhash, Kumar
    MEDICINE, 2021, 100 (13) : E25115
  • [6] A real-world data of Immune checkpoint inhibitors in solid tumors from India
    Noronha, Vanita
    Abraham, George
    Patil, Vijay
    Joshi, Amit
    Menon, Nandini
    Mahajan, Abhishek
    Janu, Amit
    Jain, Srushti
    Talreja, Vikas T.
    Kapoor, Akhil
    Singh, Gunjesh Kumar
    Khaddar, Satvik
    Gupta, Kushal
    Rathinasamy, Narmadha
    Srinivas, Sujay
    Agrawal, Amit
    Ventrapati, Pradeep
    Prabhash, Kumar
    CANCER MEDICINE, 2021, 10 (05): : 1525 - 1534
  • [7] Real-world experience and outcomes of immune-checkpoint inhibitors (ICI) in hepatocellular carcinoma (HCC)
    Paul, Samuel
    Min, Eric
    Benson, Katherine K.
    Xu, Menglin
    Noonan, Anne M.
    Mittra, Arjun
    Malalur, Pannaga G.
    Roychowdhury, Sameek
    Jin, Ning
    Hays, John L.
    Elkhatib, Rifat T.
    Rahman, Shafia
    Miller, Eric David
    Pardo, Dayssy Alexandra Diaz
    Manne, Ashish
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [8] REAL-WORLD OUTCOMES IN PATIENTS WITH PENILE SQUAMOUS CELL CARCINOMA (PSCC) RECEIVING IMMUNE CHECKPOINT INHIBITORS (ICI)
    Zhuang, Tony
    Goyal, Subir
    Brown, Jacqueline
    Carthon, Bradley
    Kucuk, Omer
    McClintock, Greta
    Yantorni, Lauren
    Bilen, Mehmet
    Master, Viraj
    Nazha, Bassel
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A498 - A499
  • [9] Clinical outcomes of EGFR plus NSCLC pts treated with immune checkpoint inhibitors (ICI).
    Piotrowska, Zofia
    Cobb, Rosemary G.
    Banwait, Mandeep
    Marcoux, Nicolas
    Mooradian, Meghan
    Dagogo-Jack, Ibiayi
    Lin, Jessica Jiyeong
    Heist, Rebecca Suk
    Shaw, Alice Tsang
    Gainor, Justin F.
    Sequist, Lecia V.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [10] Real-world evidence and clinical characteristics in patients (pts) with advanced non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICI)
    Iranzo, P.
    Callejo, A.
    Marmolejo, D.
    Assaf, J. D.
    Pardo, N.
    Navarro, A.
    Martinez-Marti, A.
    Cedres, S.
    Diaz Mejia, N. M.
    Carbonell, C.
    Amat, R.
    Frigola, J.
    Felip, E.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (04) : S767 - S767
12345